The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reliable determination of genetic ancestry from cancer-derived molecular data.
 
Pascal Belleau
No Relationships to Disclose
 
Astrid Deschênes
No Relationships to Disclose
 
David A. Tuveson
Stock and Other Ownership Interests - Cygnal Therapeutics; Leap Therapeutics; Mestag Therapeutics; Surface Oncology
Consulting or Advisory Role - Cygnal Therapeutics; Leap Therapeutics; Mestag Therapeutics; Surface Oncology
Research Funding - FibroGen; Mestag Therapeutics; Ono Pharmaceutical
Patents, Royalties, Other Intellectual Property - anti-CA199 for pancreatitis (pending); We have filed a provisional use patent for 5B1 to use to treat pancreatitis. with MabVax, which was acquired by BionTech.
 
Alexander Krasnitz
No Relationships to Disclose